218 related articles for article (PubMed ID: 9693394)
1. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
[TBL] [Abstract][Full Text] [Related]
2. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
4. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
Stanley M; Traskman-Bendz L; Dorovini-Zis K
Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
[TBL] [Abstract][Full Text] [Related]
5. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
[TBL] [Abstract][Full Text] [Related]
6. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
7. The dopamine-serotonin relationship in clozapine response.
Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
[TBL] [Abstract][Full Text] [Related]
8. In-use stability of monoamine metabolites in human cerebrospinal fluid.
Strawn JR; Ekhator NN; Geracioti TD
J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):301-6. PubMed ID: 11530989
[TBL] [Abstract][Full Text] [Related]
9. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Mov Disord; 2001 Jan; 16(1):144-9. PubMed ID: 11215576
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
11. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
13. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
Jönsson EG; Bah J; Melke J; Abou Jamra R; Schumacher J; Westberg L; Ivo R; Cichon S; Propping P; Nöthen MM; Eriksson E; Sedvall GC
BMC Psychiatry; 2004 Mar; 4():4. PubMed ID: 15102340
[TBL] [Abstract][Full Text] [Related]
14. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
15. Interactions between central monoaminergic systems: dopamine-serotonin.
Roccatagliata G; Albano C; Cocito L; Maffini M
J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
[TBL] [Abstract][Full Text] [Related]
16. Reye syndrome: monoamine metabolites in ventricular fluid.
Shaywitz BA; Venes J; Cohen DJ; Bowers MB
Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
[TBL] [Abstract][Full Text] [Related]
17. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Barkai AI; Kowalik S; Reches A
Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
[TBL] [Abstract][Full Text] [Related]
18. Effect of traumatic imagery on cerebrospinal fluid dopamine and serotonin metabolites in posttraumatic stress disorder.
Geracioti TD; Jefferson-Wilson L; Strawn JR; Baker DG; Dashevsky BA; Horn PS; Ekhator NN
J Psychiatr Res; 2013 Jul; 47(7):995-8. PubMed ID: 23540599
[TBL] [Abstract][Full Text] [Related]
19. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
20. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
